N-Acetylcysteine nebulization administered early in the course of the Acute Respiratory Distress Syndrome Save

Date Added
February 3rd, 2017
PRO Number
Pro00059094
Researcher
Judson Lewis
Keywords
Breathing, Drug Studies, Lung, Pulmonary
Summary

The acute respiratory distress syndrome (ARDS) affects 150,000 people in the US. Because of these mechanical abnormalities of the lung, ARDS patients may require mechanical ventilation. Patients with ARDS that are on mechanical ventilation have a 50% mortality rate. The overall objectives of this study are to demonstrate whether a protocol for the early use of inhaled N-acetylcysteine improves patient care and hospital stay.

Institution
Palmetto
Recruitment Contact
Alisha Henderson
803-545-5453
alisha.henderson@uscmed.sc.edu

Change_preferences

-- OR --

Create_login